These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4272617)

  • 41. [Enzymic and non-enzymic fibrinolysis during intravenous administration of trypsin].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1984; 30(2):95-100. PubMed ID: 6540008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrinogen break-down products and clotting parameters.
    Gormsen J; Laursen B
    Thromb Diath Haemorrh; 1967 May; 17(3-4):467-81. PubMed ID: 4231951
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 44. The fate of the factor-13-mediated fibrin crosslinks during clot lysis.
    Gaffney PJ
    Br J Haematol; 1973 Aug; 25(2):277. PubMed ID: 4269482
    [No Abstract]   [Full Text] [Related]  

  • 45. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fibrinogen-fibrin derivatives during difibrase therapy. Detection and course observations of high-molecular and low-molecular derivatives using agarose gel filtration].
    Asbeck F; Lechler E; van de Loo J
    Verh Dtsch Ges Inn Med; 1974; 80():1466-70. PubMed ID: 4454459
    [No Abstract]   [Full Text] [Related]  

  • 48. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction between F. XIII and fibrinolysis.
    Kazama M; Abe T
    Nihon Ketsueki Gakkai Zasshi; 1977 Dec; 40(6):1015-9. PubMed ID: 147598
    [No Abstract]   [Full Text] [Related]  

  • 50. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Biol Chem; 1973 Feb; 248(4):1395-407. PubMed ID: 4405643
    [No Abstract]   [Full Text] [Related]  

  • 51. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 53. [Use of tannin for the examination of the digestive process of casein and fibrinogen by plasmin and for the preparation of the polypeptide end products of proteolysis].
    Mejbaum-Katzenellenbogen ; Kolaczkowska M
    Acta Physiol Pol; 1970; 21(2):235-42. PubMed ID: 4248418
    [No Abstract]   [Full Text] [Related]  

  • 54. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

  • 55. Mutual interaction between platelets and fibrinogen and its derivatives.
    Stachurska J; Wegrzynowicz Z; Latallo ZS; Kopec M
    Acta Univ Carol Med Monogr; 1972; 53():17-20. PubMed ID: 4275439
    [No Abstract]   [Full Text] [Related]  

  • 56. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Influence of therapeutic defibrination and factor XIII substitution on the tensile strength of the wound in animal experiment].
    Blümel J; Köhnlein HE; Krieg G; Kutschera H
    Langenbecks Arch Chir; 1974; Suppl():245-8. PubMed ID: 4464416
    [No Abstract]   [Full Text] [Related]  

  • 58. The pathobiochemistry of DIC.
    Gaffney PJ
    Haematologica; 1980 Oct; 65(5):612-25. PubMed ID: 6450719
    [No Abstract]   [Full Text] [Related]  

  • 59. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on the role of fibrinolysis and fibrinogen degradation products (FDP) in analgesic action of morphine.
    Buczko W; Wiśniewski K
    Thromb Diath Haemorrh; 1972 Dec; 28(3):359-66. PubMed ID: 4265317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.